GNE0877 is a highly selective, orally active and brain-penetrant LRRK2 inhibitor with an IC 50 of 3 nM and a K i of 0.7 nM. GNE0877 can be used for the research of neuroscience.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Autophagy | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > LRRK2
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.